Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

Published Date: 24 Jan 2025

Median PFS in GEP-NETs increased from 11.5 to 29.7 with addition of lanreotide to everolimus

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer patients want financial screening early in care, study finds

2.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

3.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

4.

A new blood test greatly increases the ability to detect cancer.

5.

Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot